These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7085828)

  • 1. Simultaneous determination of allopurinol and oxipurinol in biological fluids by mass fragmentography.
    Lartigue-Mattei C; Chabard JL; Bargnoux H; Petit J; Berger JA
    J Chromatogr; 1982 Apr; 229(1):211-6. PubMed ID: 7085828
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of allopurinol and oxipurinol in biological fluids by high-performance liquid chromatography.
    Breithaupt H; Goebel G
    J Chromatogr; 1981 Nov; 226(1):237-42. PubMed ID: 7320148
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma oxipurinol concentrations during allopurinol therapy.
    Emmerson BT; Gordon RB; Cross M; Thomson DB
    Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
    Hosoya T; Ichida K; Tabe A; Sakai O
    Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography with polarographic and voltammetric anodic detection: simultaneous determination of allopurinol, oxipurinol and uric acid in body fluids.
    Palmisano F; Desimoni E; Zambonin PG
    J Chromatogr; 1984 Mar; 306():205-14. PubMed ID: 6715459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
    Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
    J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
    Wung WE; Howell SB
    Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass fragmentographic determination of xanthine and hypoxanthine in biological fluids.
    Chabard JL; Lartigue-Mattei C; Vedrine F; Petit J; Berger JA
    J Chromatogr; 1980 Nov; 221(1):9-17. PubMed ID: 7451628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of allopurinol and oxipurinol in human plasma and urine.
    Brown M; Bye A
    J Chromatogr; 1977 Mar; 143(2):195-202. PubMed ID: 838831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High pressure liquid chromatographic determination of allopurinol and oxipurinol in serum].
    Endele R; Lettenbauer G
    J Chromatogr; 1975 Dec; 115(1):228-31. PubMed ID: 1202065
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new and quick method for determination of allopurinol and oxipurinol in serum (author's transl)].
    Nitsche V; Mascher H
    Arzneimittelforschung; 1980; 30(11):1855-7. PubMed ID: 7192993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of allopurinol and its metabolite oxypurinol after oral administration of allopurinol alone or associated with benzbromarone in man. Simultaneous assay of hypoxanthine and xanthine by gas chromatography-mass spectrometry.
    Lartigue-Mattei C; Chabard JL; Ristori JM; Bussiere JL; Bargnoux H; Petit J; Berger JA
    Fundam Clin Pharmacol; 1991; 5(7):621-33. PubMed ID: 1778540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
    Fenner H; Schiemann O; Gikalov I
    Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.
    Kramer WG; Feldman S
    J Chromatogr; 1979 Jan; 162(1):94-7. PubMed ID: 762214
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography.
    Boulieu R; Bory C; Baltassat P; Gonnet C
    J Chromatogr; 1984 May; 307(2):469-74. PubMed ID: 6736196
    [No Abstract]   [Full Text] [Related]  

  • 16. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
    Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
    Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of allopurinol and oxipurinol in human plasma and urine by high-performance liquid chromatography.
    de Vries JX; Voss A; Kutschker C; Reiter S
    Arzneimittelforschung; 1993 Oct; 43(10):1072-5. PubMed ID: 8267672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol kinetics after massive overdosage.
    Ferner RE; Simmonds HA; Bateman DN
    Hum Toxicol; 1988 May; 7(3):293-4. PubMed ID: 3391630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
    Yamanaka H; Nishioka K; Suzuki T; Kohno K
    Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative liquid chromatography of allopurinol and oxypurinol in human plasma and urine.
    Failler JM; Farinotti R; Dauphin A
    Ther Drug Monit; 1985; 7(3):324-8. PubMed ID: 4049473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.